youtube_live
Q3 2026 – zárobky • vydané • Výnos na akciu bol prekonaný +8,63% • Výnosy boli prekonané +3,25%
Zobraziť výsledkychevron_right
NOT:ETR
Novartis
139,56 €
arrow_downward
-0,31%(-0,44) 1 d.
28. 10., 17:35:38 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOT…
Otvoriť
140,10 €
Vysoká
141,48 €
Nízka
138,94 €
Trh. kap.
314,59 mld.
Priem. obj.
5,06 tis.
Objem
5,87 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Otvoriť
140,10 €
Vysoká
141,48 €
Nízka
138,94 €
Trh. kap.
314,59 mld.
Priem. obj.
5,06 tis.
Objem
5,87 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 5 hodinami
Lilly shuffles business structure; Novartis writes off part of Avidity deal
TradingView
·
pred 20 hodinami
What Novartis (NVS) Said on Its Q3 Earnings Call
www.marketscreener.com
·
pred 1 dňom
Swiss Market Index Closes in Green; Novartis, SIG Group Shares Rise
Reuters
·
pred 1 dňom
Novartis books $2.2 billion hit from drug trial setbacks, but lifts guidance
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Webnovartis.com